LifeStance Health (LFST) Enterprise Value (2020 - 2026)

LifeStance Health has disclosed Enterprise Value across 7 years of filings, most recently posting -$76.9 million for Q1 2026.

• In Q1 2026, Enterprise Value rose 43.09% year-over-year to -$76.9 million; the TTM figure through Mar 2026 stood at -$76.9 million (up 43.09% YoY), while the FY2025 annual figure was -$175.5 million, down 43.68% from the prior year.
• Enterprise Value advanced to -$76.9 million in Q1 2026, from -$175.5 million in the prior quarter.
• Over the last five years, Enterprise Value for LFST reached as high as -$34.4 million in Q3 2023 and fell as low as -$175.5 million in Q4 2025.
• The 5-year median for Enterprise Value is -$113.0 million (2022), against an average of -$105.0 million.
• Annual changes were most pronounced in 2024 — Enterprise Value surged 71.04% — and 2025, when it slumped 272.27%.
• A 5-year view of Enterprise Value shows it stood at -$113.0 million in 2022, then jumped by 37.52% to -$70.6 million in 2023, then plunged by 72.96% to -$122.2 million in 2024, then tumbled by 43.68% to -$175.5 million in 2025, then soared by 56.17% to -$76.9 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$76.9 million, -$175.5 million, and -$141.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.